Czech, M.; Konopacka, M.; Rogoliński, J.; Maniakowski, Z.; Staniszewska, M.; Łaczmański, Ł.; Witkowska, D.; Gamian, A.
The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts. Genes 2021, 12, 729.
https://doi.org/10.3390/genes12050729
AMA Style
Czech M, Konopacka M, Rogoliński J, Maniakowski Z, Staniszewska M, Łaczmański Ł, Witkowska D, Gamian A.
The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts. Genes. 2021; 12(5):729.
https://doi.org/10.3390/genes12050729
Chicago/Turabian Style
Czech, Monika, Maria Konopacka, Jacek Rogoliński, Zbigniew Maniakowski, Magdalena Staniszewska, Łukasz Łaczmański, Danuta Witkowska, and Andrzej Gamian.
2021. "The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts" Genes 12, no. 5: 729.
https://doi.org/10.3390/genes12050729
APA Style
Czech, M., Konopacka, M., Rogoliński, J., Maniakowski, Z., Staniszewska, M., Łaczmański, Ł., Witkowska, D., & Gamian, A.
(2021). The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts. Genes, 12(5), 729.
https://doi.org/10.3390/genes12050729